Wall Street analyst estimates for MetLife, Inc. (MET): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings.
Consensus price target
$108.25 (+8 % vs price $100.67)
between $103.00 and $111.00 · 7 targets published in the last quarter
Closing price, Nov 3
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $79.4B | $79.1B – $80.0B | $10.24 | 11 |
| 2027E | $83.3B | $80.9B – $85.0B | $11.16 | 11 |
| 2028E | $87.1B | $84.5B – $89.5B | $12.44 | 7 |
Figures in USD · consensus as of November 1, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 26 |
| Hold | 7 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 33 |
| Avg rating (−2 sell to +2 buy) | 0.79 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-04 | $2.77 | ||
| 2026-08-05 | $2.43 | $2.30 | +5.7% |
| 2026-05-06 | $2.42 | $2.27 | +6.6% |
| 2026-02-04 | $2.58 | $2.34 | +10.3% |
| 2025-11-05 | $2.34 | $2.31 | +1.3% |
| 2025-08-06 | $2.02 | $2.15 | -6.0% |
| 2025-04-30 | $1.96 | $2.00 | -2.0% |
| 2025-02-05 | $2.08 | $2.11 | -1.4% |
Valuation Ratios
| P/E Ratio | 19.32 |
| Price / Book | 2.39 |
| Dividend Yield | 2.33% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $60.53B | $62.31B | $67.94B | $69.62B | $67.89B | $63.37B | $67.97B | $67.71B | $69.94B | $77.08B |
| Cost of Revenue | $46.57B | $48.85B | $52.04B | $53.43B | $52.42B | $46.53B | $49.03B | $50.42B | $50.94B | $49.06B |
| Gross Profit | $13.96B | $13.46B | $15.90B | $16.19B | $15.47B | $16.84B | $18.94B | $17.29B | $19.00B | $28.02B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $6.87B | $6.72B | $6.46B | $6.55B | $5.78B | $5.75B | $5.86B | $6.18B | $5.99B | 0 |
| Operating Expenses | $9.67B | $9.93B | $9.59B | $9.39B | $8.54B | $8.32B | $12.57B | $15.13B | $13.38B | $23.36B |
| Operating Income | $4.28B | $3.54B | $6.31B | $6.79B | $6.93B | $8.52B | $6.36B | $2.16B | $5.62B | $4.66B |
| EBITDA | $6.09B | $5.46B | $8.06B | $8.38B | $8.46B | $10.13B | $7.97B | $3.92B | $7.37B | $6.47B |
| Interest Expense | $1.16B | $1.13B | $1.12B | $955.0M | $913.0M | $920.0M | $938.0M | $1.04B | $1.04B | $1.06B |
| Pre-tax Income | $4.28B | $3.54B | $6.31B | $6.79B | $6.93B | $8.52B | $6.36B | $2.16B | $5.62B | $4.66B |
| Income Tax | $693.0M | -$1.47B | $1.18B | $886.0M | $1.51B | $1.64B | $1.06B | $560.0M | $1.18B | $1.26B |
| Net Income | $850.0M | $4.01B | $5.12B | $5.90B | $5.41B | $6.86B | $5.28B | $1.58B | $4.43B | $3.38B |
| EPS | $0.68 | $3.74 | $4.95 | $6.10 | $5.72 | $7.70 | $6.35 | $1.82 | $5.98 | $4.80 |
| EPS (Diluted) | $0.67 | $3.74 | $4.91 | $6.06 | $5.68 | $7.65 | $6.30 | $1.81 | $5.94 | $4.80 |
| Shares Outstanding (Diluted) | 1,095.5 M | 1,043.6 M | 1,013.9 M | 944.4 M | 913.2 M | 869.4 M | 808.9 M | 762.4 M | 711.1 M | 665.0 M |
Price
| Price | $100.67 (closing price, November 3, 2026) |
| Market Cap | $64.0B |
| Exchange | NYSE |
| Country | US |
Related companies: MFC · AFL · PRU · UNM · GL · PRI · VOYA · LNC
Explore sector: Financial Services · Insurance - Life
More sections of MET: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks